Table 1 Primary or most severe presenting complaint for all Cancer Urgent Assessment Clinic presentations (based on UKONS toxicity grading [27])
Primary presenting complaint | Total; n=246, n (%) | UKONS red grading, n (%) |
|---|---|---|
General/systemic | ||
Pain | 51 (20.7%) | 27 (25.7%) |
Fever—on systemic treatment | 28 (11.4%) | 28 (26.7%) |
Infection | 12 (4.9%) | 1 (0.9%) |
Performance status | 10 (4.1%) | 4 (3.8%) |
Fatigue | 4 (1.6%) | 1 (0.9%) |
105 (42.7%) | 61/105 (58.1%) | |
Gastrointestinal/urinary | ||
Diarrhea | 15 (6.1%) | 5 (2.0%) |
Urinary disorder | 11 (4.5%) | 5 (2.0%) |
Nausea | 9 (3.7%) | 2 (0.8%) |
Vomiting | 8 (3.3%) | 2 (0.8%) |
Mucositis | 6 (2.4%) | 3 (1.2%) |
Constipation | 5 (2.0%) | 3 (1.2%) |
Anorexia | 1 (0.4%) | 0 (0.0%) |
55 (22.4%) | 20/55 (36.3%) | |
Cardiovascular | ||
Dyspnea | 25 (9.8%) | 7 (24.1%) |
Chest pain | 2 (0.8%) | 2 (6.9%) |
Bleeding | 2 (0.8%) | 2 (6.9%) |
29 (22.4%) | 11/29 (37.9%) | |
Central nervous system | ||
Neurosensory/motor disturbance | 10 (4.1%) | 4 (30.8%) |
Confusion/cognitive disturbance | 3 (1.2%) | 0 (0.0%) |
13 (5.3%) | 4/13 (30.8%) | |
Skin/eyes | ||
Rash | 4 (1.6%) | 2 (25.0%) |
Ocular/eye problems | 2 (0.8%) | 0 (0.0%) |
Extravasation | 1 (0.4%) | 1 (12.5%) |
Palmar plantar syndrome | 1 (0.4%) | 0 (0.0%) |
38 (3.3%) | 3/8 (3.7.5%) | |
Othera | ||
36 (14.6%) | 17/36 (47.2%) | |